Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Gilead Sciences Inc (GILD)

2014-12-19@15:12:13 ET
Ono Pharmaceutical signs licensing agreement with Gilead Sciences (DTF)

2014-12-19@01:00:04 ET
ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases (BIZ)

2014-12-18@12:40:47 ET
Gilead Sciences Crosses Above its 10-day MA (GILD) (F78)

2014-12-18@12:29:14 ET
Gilead Sciences (GILD) Showing Bearish Technicals (FBM)

2014-12-18@11:58:26 ET
Shares of Gilead Sciences Receive a Boost, Up 2.4% (F77)

2014-12-18@05:04:34 ET
Liver Fibrosis - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:58:44 ET
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:42 ET
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:08:11 ET
Myelofibrosis - Pipeline Review, H1 2014 (MTO)

2014-12-18@02:01:21 ET
Gilead Sciences Taps Philippe Bishop, MD as SVP, Hematology and Oncology Therapeutics (CLM)

2014-12-17@04:11:47 ET
Gilead appoints senior vice president, hematology and oncology therapeutics (DTM)

2014-12-16@16:44:38 ET
Gilead Sciences Set to Possibly Rebound After Yesterday's Selloff of 2.62% (PSM)

2014-12-16@16:44:08 ET
SmarTrend Watching for Potential Rebound in Shares of Gilead Sciences After 2.62% Loss (PSM)

2014-12-16@13:24:34 ET
Next Support Level for Gilead Sciences (GILD) is $100.25 (PSM)

2014-12-16@13:21:20 ET
Gilead Sciences (GILD) Approaches New Downside Target of $100.25 (F79)

2014-12-16@12:23:01 ET
Gilead Sciences (GILD) Showing Bearish Technicals With Resistance At $107.39 (FBM)

2014-12-16@11:27:41 ET
Global Herpes Market Report 2014-2018 - Key Vendors are Gilead Sciences, GSK, Merck & Novartis (MTO)